Development of breast cancer in women with breast cysts: A case report

Vladan Lekovski ,
Vladan Lekovski
Contact Vladan Lekovski

Clinic for Surgery, Clinical Hospital Centar Zemun , Belgrade , Serbia

Goran Bogdanovic ,
Goran Bogdanovic

Department of General Surgery, General Hospital Bor Serbia

Milan Jovanovic ,
Milan Jovanovic

Department of General Surgery, Medical Faculty of the University of Defense, Military Medical Academy , Belgrade , Serbia

Zoran Ciric ,
Zoran Ciric

Department of General Surgery, Medical Faculty of the University of Defense, Military Medical Academy , Belgrade , Serbia

Mihailo Bezmarevic ,
Mihailo Bezmarevic

Department of General Surgery, Medical Faculty of the University of Defense, Military Medical Academy , Belgrade , Serbia

Jovana Stevanovic ,
Jovana Stevanovic

Department of General Surgery, Medical Faculty of the University of Defense, Military Medical Academy , Belgrade , Serbia

Aleksandar Lazic
Aleksandar Lazic

Clinic for Surgery, Clinical Hospital Centar Zemun , Belgrade , Serbia

Published: 01.01.2020.

Volume 36, Issue 1 (2020)

pp. 1849-1856;

Abstract

Breast cysts are the most common benign changes at women aged 35 to 50 years old. Usually there isn’t highest risk for breast cancer in women with cystic changes, but in the rare cases cancer can be found in association with a cyst. We reported two patients aged 33 and 45 years old. Both of them had breast cystic changes. We performed Fine Needle Aspiration (FNA) with cytological examination of the aspirated content, the breast ultrasound examination and mammography for second patient. Cysts were surgically removed and sent to the final histopathological verification. Patient 33 years old was diagnosed medullary breast cancer and undergone axillary dissection and breast sentinel node biopsy (SNB) with histopathological (HP) and immunohistochemical (IHC) findings, after that patient was treated with adjuvant chemotherapy. In patient 44 years old was diagnosed mucinous breast cancer, performed partial breast resection with axillary dissection and applied adjuvant hormonal therapy. Radiotherapy was conducted on both patients and they were followed for 3 years by a regional oncologic dispensary. Although malignant cells wasn’t find by cytological examination we have to be careful because in the wall of the cyst may be malignant cells, so histopathological (HP) and immunohistochemical (IHC) findings are the most relevant diagnostic procedures. Primary treatment of breast cancer is surgery, but important role in management have postoperative radiotherapy, chemotrerapy and hormonal therapy. Survival depends on the size, type of tumor and affected lymph nodes. Prognostic parameters which should be considered are: menopausal status, tumor size, tumor location, lymph node status, tumor type, nuclear grade, histological grade,
hormone receptors and tumor markers.

Keywords

References

1.
Moss HA, Britton PD, Flower CD, Freeman AH, Lomas DJ, Warren RM. How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? *Clin Radiol*. 54:676–82.
2.
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version. *Arch Pathol Lab Med*. 134(7).
3.
Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. *Eur Radiol*. 20(3):734–42.
4.
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. *J Natl Compr Canc Netw*. 20097(10):1060–96.
5.
Shah R, Kelly Rosso SDN. Pathogenesis, prevention, diagnosis and treatment of breast cancer. *World J Clin Oncol*. 5(3):283–98.
6.
Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. *Cancer*. 71(4):1258–65.
7.
Benign breast disease and the risk of breast cancer. *N Engl J Med*. 353(3):229–37.
8.
Dumitru A, Procop A, Iliesiu A, Tampa M, Mitrache L, Costache M, et al. Mucinous Breast Cancer: a Review Study of 5 Year Experience from a Hospital-Based Series of Cases. *Maedica (Buchar)*. 10(1):14–8.
9.
Huober J, Gelber S, Goldhirsch A, Coates S, Viale G, Ohlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. *Annals of Oncology*. 23:2843–51.
10.
Pervez S, Khan H. Infiltrating ductal carcinoma breast with central necrosis closely mimicking ductal carcinoma in situ. comedo type); a case series *Journal of Medical Case Reports*. 1(83).
11.
Voyvoda N. Simple breast cysts: should we treat or not? *Diagn Interv Radiol*. 23(86).
12.
Voyvoda N. Simple breast cysts: should we treat or not? *Diagn Interv Radiol*. 23(86).
13.
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC.
14.
Bruzzi P, Dogliotti L, Naldoni C, Bucchi L, Costantini M, Cicognani A, et al. Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. *BMJ*. 314(925).
15.
Man C, Wei WZ, Wen PW. Cystic breast lesions by conventional ultrasonography: sonographic subtype-pathologic correlation and BI-RADS Assessment. *Arch Med Sci*. 10(1):76–83.
16.
Vorherr H. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. *Am J Obstet Gynecol*. 154(1):161–79.
17.
Gokhale S. Ultrasound characterization of breast masses. *Indian J Radiol Imaging*. 19(3):242–7.
18.
Chen YY, Fang WH, Wang CC, Kao TW, Chang YW, Yang HF, et al. Examining the Associations among Fibrocystic Breast Change. Total Lean Mass, and Percent Body Fat *Sci Rep*. 8(1).
19.
Klein S. Evaluation of Palpable Breast Masses. *American Family Physician*. 71(9):1731–8.
20.
Smith AR, Andrews K, Brooks D, DeSantis CE, Fedewa AS, Lortet-Tieulent J, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. *CA Cancer J Clin*. 66:95–114.
21.
Gerzić Z, hirurgije DMO. Medicinska knjiga.
22.
Guray M, Sahin AA. Benign Breast Diseases: Classification. Diagnosis, and Management *The Oncologist*. 11(5):435–49.
23.
Ferlay J, Autier P, Boniol M. Estimates of the cancer incidence and mortality in Europe in 2006. *Ann Oncol*. 18:581–92.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners